Kinesis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth -15.45%
- Profit Growth -73.73%
- Ebitda -73.85%
- Net Worth 25.46%
- Total Assets -34.91%
About Kinesis Pharmaceuticals
Kinesis Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 March 1994 and has a history of 30 years and ten months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹0.60 M.
Arumugam Olaganathan, Viswanathan Shanmugasundaram, and Olaganathan Meenakshi serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1994PTC027081
-
Company No.
027081
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Mar 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Kinesis Pharmaceuticals Private Limited offer?
Kinesis Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Fever.
Who are the key members and board of directors at Kinesis Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arumugam Olaganathan
|
Director | 15-Mar-2010 | Current |
|
Viswanathan Shanmugasundaram
|
Additional Director | 01-Aug-2022 | Current |
|
Olaganathan Meenakshi
|
Additional Director | 27-Jan-2011 | Current |
Financial Performance of Kinesis Pharmaceuticals.
Kinesis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.45% decrease. The company also saw a substantial fall in profitability, with a 73.73% decrease in profit. The company's net worth Soared by an impressive increase of 25.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kinesis Pharmaceuticals?
Unlock access to Kinesis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Flaring Formulations Private LimitedViswanathan Shanmugasundaram is a mutual person
-
Azidus Laboratories LimitedViswanathan Shanmugasundaram is a mutual person
-
Zota Pharmaceuticals Private LimitedArumugam Olaganathan is a mutual person
-
Atoz Pharmaceuticals Private Limited
Viswanathan Shanmugasundaram is a mutual person
-
Cosmo Clinical Research LlpArumugam Olaganathan and Olaganathan Meenakshi are mutual person
-
Baddi Print Packs Private Limited
Viswanathan Shanmugasundaram is a mutual person
Charges (Loans)
₹0.06 Cr
₹0
Charges Breakdown by Lending Institutions
- The Vysya Bank Limited : 0.05 Cr
- Indian Overseas Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 1998 | The Vysya Bank Limited | ₹0.50 M | Open |
| 16 Feb 1995 | Indian Overseas Bank | ₹0.10 M | Open |
How Many Employees Work at Kinesis Pharmaceuticals?
Kinesis Pharmaceuticals has a workforce of 33 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kinesis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinesis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
